India's Windlas Biotech hits record high on Q4 profit jump

Windlas Biotech

21/05/2024 05:37

** Shares of Windlas Biotech  WINL.NS  up as much as 17.2%
to a record high of 648 rupees
    ** The pharmaceutical products manufacturer reported a 48.5%
Y/Y rise in its consolidated net profit on Monday 
    ** Revenue from operations rose 21.7% 
    ** EBITDA margin expands to 12.8% from 11.7% a year earlier
    ** WINL on track for a second straight session of gains, if
trends hold
    ** More than 442,000 shares traded by 10:05 a.m. IST, 8.8x
its 30-day avg; busiest day yet since March 1s 
    ** Including session's move, stock is up 44.2% YTD 
        
($1 = 83.3275 Indian rupees)

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))